Stock screenerAll disclosures →
EDGAR →
UNCY
Conviction 32HealthcareScan · Mon, Aug 10, 2026UNCY$5.01-1.18%
ResistanceSupportVol 14Vol MA14 803.27K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price5.01
Change-1.18%
Gap+0.20%
Rel volume2.01×
Avg volume839.52K
Avg $ vol4.34M
SMA 205.20
SMA 506.14
SMA 2006.38
Price vs 50-18.34%
Price vs 200-21.42%
MA stackbearish
50/200 crossdeath · 5d
Supertrenddown · 6.03
RSI (14)42
MACD hist0.06
MACD cross—
Stoch %K / %D28 / 30
ADX (14)18
+DI / −DI20 / 28
RSI divergence—
MACD divergenceBullish
ATR %+7.75%
ADR %5.78%
52w high8.56
52w low3.74
From 52w high-41.47%
Above 52w low+33.96%
New 52w highNo
SqueezeOn · 9d
Bollinger width17.74%
%B0.30
Donchian pos25.86%
Donchian high5.87
Donchian low4.71
AVWAP (52w high)6.02
vs AVWAP high-16.75%
AVWAP (52w low)6.12
vs AVWAP low-18.15%
OBV trendFlat
Chaikin MF (20)-0.15
Today vs 20d2.01×
Avg vol (14d)803.27K
Avg vol (20d)839.52K
Avg $ vol (20d)4.34M
Market cap133.77M
RS 3m (vs SPY)-41.19%
RS 6m (vs SPY)-32.21%
RS line new highNo
Trend template3/8
Technical rank14.5
1 week-0.89%
1 month-3.84%
3 months-36.90%
6 months-25.11%
1 year+23.40%
YTD-13.62%
P/E-5.04
P/B3.55
P/S198.17
P/FCF-4.27
EPS-1.67
Div yield0.82%
ROE-70.43%
ROA-41.23%
Debt/Eq—
Current2.40
EV/EBITDA-3.31
Gross margin—
Net margin—
Rev growth0.00%
EPS growth27.70%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value96.4M
Revenue675K
Net income-12.82M
Gross profit—
Free cash flow-31.34M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out27.39M
Employees22
ListedTue, Jul 13, 2021
Free float26.1M
Float %97.8%
Short interest4.94M
Days to cover2.5d
Short volume43.9%
Squeeze score68 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction32 / 100
Pattern quality—
Tech rank14.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance7.25
Support4.32
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in UNCY
No recent disclosed trades by Congress in UNCY. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in UNCY · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kenkare-Mitra Sara Director · Restricted Stock Units · 2026-05-14 | Grant | 47.94K | — | 2026-05-14 | 2026-07-28 |
Laumas Sandeep Director · Restricted Stock Units · 2026-05-14 | Grant | 47.94K | — | 2026-05-14 | 2026-07-28 |
Gupta Shalabh K. CEO · Restricted Stock Units · 2026-05-14 | Grant | 762.2K | $0 | 2026-05-14 | 2026-05-21 |
Kenkare-Mitra Sara Director · Restricted Stock Units · 2026-05-14 | Grant | 42.1K | $0 | 2026-05-14 | 2026-05-21 |
Kenkare-Mitra Sara Director · Restricted Stock Units · 2026-05-14 | Grant | 84.2K | $0 | 2026-05-14 | 2026-05-21 |
Gupta Pramod EVP, Pharmaceuticals and BD · Restricted Stock Unit · 2026-05-14 | Grant | 169.5K | $0 | 2026-05-14 | 2026-05-20 |
Townsend John CFO · Restricted Stock Unit · 2026-05-14 | Grant | 169.5K | $0 | 2026-05-14 | 2026-05-20 |
Jermasek Douglas EVP, Corporate Strategy · Restricted Stock Units · 2026-05-14 | Grant | 169.5K | $0 | 2026-05-14 | 2026-05-20 |
Laumas Sandeep Director · Restricted Stock Units · 2026-05-14 | Grant | 42.1K | $0 | 2026-05-14 | 2026-05-18 |
Laumas Sandeep Director · Restricted Stock Units · 2026-05-14 | Grant | 84.2K | $0 | 2026-05-14 | 2026-05-18 |
SEC filings
EDGAR filings in UNCY · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.